Thu, Apr 25, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Herbalife, Pfizer halted on legal news

Thursday, March 13, 2014

Bailey McCann, Opalesque New York:

Bill Ackman may finally be vindicated in his high profile Herbalife bet. Shares of the stock were halted today prior to an announcement by the Federal Trade Commission (FTC) that it will be investigating the company. Ackman made a high profile bet against Herbalife saying it was a Ponzi scheme. Since then, a number of other managers and funds have come to its defense.

"Herbalife welcomes the inquiry given the tremendous amount of misinformation in the marketplace," the Cayman Islands-based company said today in a statement. "We are confident that Herbalife is in compliance with all applicable laws and regulations."

Shares of the company closed above $60 today, which is surprising given the announcement and may indicate the view of the broader market on the company. The FTC, along with the U.S. Securities and Exchange Commission, had been asked by Senator Edward Markey, a Massachusetts Democrat, to look into Herbalife’s business practices. According to the New York Times, Pershing Square hired a former Markey aide as part of his campaign against the company.

Shares of Pfizer were also halted today pending news that the company would be appealing a patent court decision on Celebrex. Celebrex is a brand-name painkiller that is widely prescribed. Pfizer held the origina......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1